User:Mr. Ibrahem/Isavuconazonium
From Wikipedia, the free encyclopedia
Isavuconazonium, sold under the brand name Cresemba, is a medication used to treat invasive aspergillosis and mucormycosis.[4][3] For mucormycosis, it is used when amphotericin B is not suitable.[5] It may be taken by mouth or given by gradual injection into a vein.[3]
Clinical data | |
---|---|
Trade names | Cresemba |
Other names | Isavuconazonium sulfate |
AHFS/Drugs.com | Monograph |
Pregnancy category |
|
Routes of administration | By mouth, intravenous (IV) |
Drug class | Antifungal (triazole)[2] |
Legal status | |
Legal status | |
Chemical and physical data | |
Formula | C35H35F2N8O5S |
Molar mass | 717.77 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
Common side effects include liver problems, nausea, shortness of breath, abdominal pain, diarrhea, headache, low potassium and rash.[4] Other side effects may include anaphylaxis and short QT.[3][6] Use in pregnancy may harm the baby.[3] It is a antifungal medication of the triazole class and works after being converted into isavuconazole in the body.[2]
Isavuconazonium was approved for medical use in the United States and Europe in 2015.[6][4] In the United Kingdom a vial of 200 mg cost the NHS about £300 as of 2021.[5] This amount in the United States costs about 350 USD.[7]